Certificate purusant to Regulation 74(5) of the SEBI (D&P) Regulations, 2018, for the quarter ended on 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has submitted a certificate from its Registrar and Transfer Agent (RTA), Bigshare Services Pvt. Ltd., confirming compliance with SEBI's Regulation 74(5) for the quarter ended 30 September 2025. The certificate confirms that all securities received from depository participants for dematerialization during the quarter were properly processed and confirmed to the depositories. It also confirms that physical share certificates were mutilated and cancelled after verification, and the depository's name was substituted as the registered owner in the company's register of members within the required 15-day timeline. This is a routine quarterly compliance submission required of all listed companies.
This is a standard regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms the company's RTA is handling dematerialization requests in line with SEBI rules.